Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04704154
Title A Trial to Learn Whether Regorafenib in Combination With Nivolumab Can Improve Tumor Responses and How Safe it is for Participants With Solid Tumors
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Bayer
Indications

esophagus squamous cell carcinoma

cholangiocarcinoma

anaplastic astrocytoma

intrahepatic cholangiocarcinoma

head and neck squamous cell carcinoma

gallbladder cancer

glioblastoma

malignant astrocytoma

oropharynx cancer

pancreatic ductal adenocarcinoma

Therapies

Nivolumab + Regorafenib

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.